ZS Pharma's (ZSPH) Price Target Raised to $83 at BMO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
ZS Pharma's (ZSPH) Price Target Raised to $110 at William Blair
September 11, 2015 8:21 AM EDTWilliam Blair maintained an Outperform rating on ZS Pharma (NASDAQ: ZSPH) and raised its price target to $110.00 (from $75.00).
For an analyst ratings summary and ratings history on ZS Pharma click here. For more ratings news on ZS Pharma click here.
Shares of ZS Pharma closed at $74.73 yesterday.
... MoreZS Pharma (ZSPH) to Resume Trading at 5:50 PM
September 10, 2015 5:36 PM EDTZS Pharma (NASDAQ: ZSPH) to Resume Trading at 5:50 PM
... MoreZS Pharma (ZSPH) Participated in Preliminary Discussions with Actelion
September 10, 2015 5:32 PM EDTZS Pharma, Inc. (Nasdaq: ZSPH), today confirmed that it has participated in preliminary discussions with Actelion Ltd. (OTC: ALIOF) regarding a potential strategic transaction. ZS Pharma regularly and routinely explores opportunities with various strategic... More
Market Wrap: Markets Gain as Volatility Subsides; GE Moves to Sell More Assets; Initial Claims Flat W/W
September 10, 2015 5:24 PM EDTMarket wrap for September 10th
End of the Day: S&P 500 up 10.3 to 1,952.29; Dow Jones up 16,330.40 to 76.8; Nasdaq up 39.7 to 4,796.26
Market Brief: U.S. markets posted firm gains Thursday as volatility in the market continued to ebb.
Initial claims came in flat last week.
GE moved to sell additional assets.
lululemon athletica moved lower as its FY15 EPS outlook still trailed estimates.
Google launched its Android Pay... More
Actelion Confirms Discussions with ZS Pharma (ZSPH)
September 10, 2015 5:17 PM EDTActelion Ltd confirmed today that it has initiated preliminary discussions with ZS Pharma, Inc. (Nasdaq: ZSPH) without any commitment on either party.
Actelion does not intend to make any further comments at this time.
... MoreZS Pharma (ZSPH) halted with news pending
September 10, 2015 4:32 PM EDTZS Pharma (NASDAQ: ZSPH) trading halted with news pending.
... MoreRelypsa (RLYP) Gains in Sympathy with ZS Pharma (ZSPH)
September 10, 2015 2:39 PM EDTRelypsa (NASDAQ: RLYP) gained in sympathy with ZS Pharma (NASDAQ: ZSPH) after Bloomberg reported Actelion made a preliminary offer to buy the company last month.
Note: Relypsa is seeking regulatory approval of Patiromer FOS for the treatment of... More
ZS Pharma (ZSPH) Halted on LUDP
September 10, 2015 2:25 PM EDTZS Pharma (NASDAQ: ZSPH) Halted on LUDP
... MoreActelion Said to Make Approach for ZS Pharma (ZSPH)
September 10, 2015 2:24 PM EDT(Updated - September 10, 2015 2:30 PM EDT)
Actelion (OTCBB: ACLIOF) said to make approach for ZS Pharma (Nasdaq: ZSPH), according to Bloomberg headlines.
The deal is said to be valued at about $2.5... More
UPDATE: ZS Pharma (ZSPH) Shares Surge; Conference Cancellation Confirmed
September 10, 2015 10:14 AM EDT(Updated - September 10, 2015 1:02 PM EDT)
ZS Pharma (NASDAQ: ZSPH) shares surged Thursday, rising over 15%. The cause of the spike wasn't clear, though unconfirmed market chatter tied move to a potential conference cancellation.
Update:
According to Bloomberg a Citi spokesperson said ZS... More
